TareBio 带着癌症疫苗项目加入 YC 的夏季批次
医师-科学家 Eta Atolia 正在将多年的新抗原和合成生物学研究转化为一家位于洛杉矶的生物技术公司。
By Ryan Merket · Published
Primary source: X
为何重要
TareBio 将 YC 的公司构建机制与一位医师-科学家配对，该科学家的研究直接解决了癌症疫苗最难的问题之一：选择能产生有用免疫反应的靶点。
TareBio has surfaced with a cancer vaccine program led by physician-scientist Eta Atolia (@eatolia), whose academic work has focused on tumor immunology, vaccine neoantigens and engineered cancer therapies.
https://x.com/eatolia/status/2084727101719265597
…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.